Anti-inflammatory

Etoricoxib

A selective COX-2 inhibitor NSAID used in oral formulations for osteoarthritis, rheumatoid arthritis, and acute pain and gout flares.

Etoricoxib is a next-generation selective COX-2 inhibitor API manufactured by NovaAcura Biotech under GMP-compliant conditions. Full batch documentation and regulatory support are available for global formulation partners.

Applications & Uses

A selective COX-2 inhibitor NSAID used in oral formulations for osteoarthritis, rheumatoid arthritis, and acute pain and gout flares.

Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.

Need This Molecule at Scale?

Get in touch for pricing, lead times and full regulatory documentation.

Get In Touch